ArticleFrontiers in immunology2021

Treatment With Cladribine Selects IFNγ+IL17+ T Cells in RRMS Patients - An

Minodora Dobreanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.